CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market sale Chief Financial Officer sold 33,000 shares at an average $29.99 ($989,694)
- 4 Open-market sale President and CEO sold 19,578 shares at $29.43 ($576,141)
- 4 Open-market sale Chief Medical Officer sold 23,840 shares at $30.00 ($715,200)
- 4 Open-market sale Director sold 3,819 shares at $30.00 ($114,570)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale Chief Financial Officer sold 2,548 shares at $26.69 ($68,010)
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 6,526 shares at $25.01 ($163,215)
- 4 Open-market sale Director sold 10,000 shares at $25.01 ($250,078)
- 8-K Event Regulation FD disclosure
Page 28 of 41 · 801 filings